Worldwide genetic variability of the duffy binding protein: Insights into Plasmodium vivax vaccine development

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  de Sousa, Taís Nóbrega ^a   Carvalho, Luzia Helena ^a   de Brito, Cristiana Ferreira Alves ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY BINDING PROTEIN; PLASMODIUM VIVAX VACCINE; PROTOZOAL VACCINE; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BAYES THEOREM; EPITOPE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; UNINDEXED SEQUENCE;

PLASMODIUM VIVAX;

EID: 79961000173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022944     Document Type: Article

References (63)

1. Mendis K, Sina BJ, Marchesini P, Carter R, (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
2. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
3. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax malaria: Neglected and not benign. Am J Trop Med Hyg 77: 79-87.
4. Price RN, Douglas NM, Anstey NM, (2009) New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 22: 430-435.
5. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MP, et al. (2010) Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
6. Mons B, Collins WE, Skinner JC, Vanderstar W, Croon J, et al. (1988) Plasmodium vivax- in vitro growth and reinvasion in red blood-cells of aotus-nancymai. Exp Parasitol 66: 183-188.
7. Horuk R, Chitnis C, Darbonne W, Colby T, Rybicki A, et al. (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182-1184.
8. Singh AP, Ozwara H, Kocken CHM, Puri SK, Thomas AW, et al. (2005) Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Mol Microbiol 55: 1925-1934.
9. Adams JH, Sim BKL, Dolan SA, Fang XD, Kaslow DC, et al. (1992) A family of erythrocyte binding-proteins of malaria parasites. Proc Natl Acad Sci U S A 89: 7085-7089.
10. Michon P, Stevens JR, Kaneko O, Adams JH, (2002) Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites. Mol Biol Evol 19: 1128-1142.
11. Singh S, Hora R, Belrhali H, Chitnis C, Sharma A, (2006) Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439: 741-744.
12. Bolton MJ, Garry RF, (2011) Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines. Virol J 8: 45.
13. Ceravolo IP, Souza-Silva FA, Fontes CJF, Braga EM, Madureira AP, et al. (2008) Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand J Immunol 67: 270-278.
14. Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, et al. (2007) Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 4: 1940-1948.
15. Michon P, Fraser T, Adams JH, (2000) Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect Immun 68: 3164-3171.
16. King C, Michon P, Shakri A, Marcotty A, Stanisic D, et al. (2008) Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 105: 8363-8368.
17. Miller L, Mason S, Clyde D, McGinniss M, (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302-304.
18. Welch SG, McGregor IA, Williams K, (1977) The Duffy blood group and malaria prevalence in Gambian West Africans. Trans R Soc Trop Med Hyg 71: 295-296.
19. Sousa TN, Sanchez BAM, Ceravolo IP, Carvalho LH, Brito CFA, (2007) Real-time multiplex allele-specific polymerase chain reaction for genotyping of the Duffy antigen, the Plasmodium vivax invasion receptor. Vox Sang 92: 373-380.
20. Kasehagen L, Mueller I, Kiniboro B, Bockarie M, Reeder J, et al. (2007) Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One 2: e336.
21. Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, et al. (2006) Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in western Kenya. Am J Trop Med Hyg 75: 575-581.
22. Cavasini CE, de Mattos LC, Couto AAD, Bonini-Omingos CR, Valencia SH, et al. (2007) Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg 101: 1042-1044.
23. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 107: 5967-5971.
24. Sousa TN, Ceravolo IP, Fontes CJF, Couto A, Carvalho LH, et al. (2006) The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol Biochem Parasitol 146: 251-254.
25. Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA, (1996) Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol 78: 269-272.
26. Tsuboi T, Kappe SH, Alyaman F, Prickett MD, Alpers M, et al. (1994) Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding-protein. Infect Immun 62: 5581-5586.
27. Xainli J, Adams J, King C, (2000) The erythrocyte binding motif of Plasmodium vivax duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol 111: 253-260.
28. Kho W, Chung J, Sim E, Kim D, Chung W, (2001) Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J Parasitol 39: 143-150.
29. Gosi P, Fukuda M, Schaecher K, Lanar D, Khusmith S, et al. (2007) Polymorphisms of Plasmodium vivax duffy binding protein in isolates from Thai patients. Am J Trop Med Hyg 77: 247-247.
30. Babaeekho L, Zakeri S, Djadid ND, (2009) Genetic mapping of the duffy binding protein (DBP) ligand domain of Plasmodium vivax from unstable malaria region in the Middle East. Am J Trop Med Hyg 80: 112-118.
31. Premaratne PH, Aravinda BR, Escalante AA, Udagama-Randeniya PV, (2011) Genetic diversity of Plasmodium vivax Duffy Binding Protein II (PvDBPII) under unstable transmission and low intensity malaria in Sri Lanka. Infect Genet Evol Apr 28. [Epub ahead of print].
32. VanBuskirk KM, Cole-Tobian JL, Baisor M, Sevova ES, Bockarie M, et al. (2004) Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J Infect Dis 190: 1556-1562.
33. Ceravolo IP, Sanchez BA, Sousa TN, Guerra BM, Soares IS, et al. (2009) Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin Exp Immunol 156: 502-510.
34. Cole-Tobian JL, Michon P, Biasor M, Richards JS, Beeson JG, et al. (2009) Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous Plasmodium vivax strains in Papua New Guinean children. Infect Immun 77: 4009-4017.
35. Sousa TN, Tarazona-Santos EM, Wilson DJ, Madureira AP, Falcao PR, et al. (2010) Genetic variability and natural selection at the ligand domain of the Duffy binding protein in Brazilian Plasmodium vivax populations. Malar J 9: 334.
36. Hall T, (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41: 95-98.
37. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
38. Excoffier L, Laval G, Schneider S, (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinformatics Online 1: 47-50.
39. Falush D, Stephens M, Pritchard JK, (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164: 1567-1587.
40. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
41. Rosenberg N, (2004) DISTRUCT: a program for the graphical display of population structure. Mol Ecol Notes 4: 137-138.
42. Gosi P, Khusmith S, Khalambaheti T, Lanar D, Schaecher K, et al. (2008) Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates. Malar J 7: 112.
43. Cole-Tobian JL, Cortes A, Baisor M, Kastens W, Xainli J, Bockarie M, Adams JH, King CL, (2002) Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein. J Infect Dis 186: 531-539.
44. Cole-Tobian JL, Biasor M, King CL, (2005) High complexity of Plasmodium vivax infections in Papua New Guinean children. Am J Trop Med Hyg 73: 626-633.
45. Anderson T, Haubold B, Williams J, Estrada-Franco J, Richardson L, et al. (2000) Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 17: 1467-1482.
46. Rezende A, Tarazona-Santos E, Fontes C, Souza J, Couto A, et al. (2010) Microsatellite loci: determining the genetic variability of Plasmodium vivax. Trop Med Int Health 15: 718-726.
47. Ferreira MU, Karunaweera ND, da Silva-Nunes M, da Silva NS, Wirth DF, et al. (2007) Population structure and transmission dynamics of plasmodium vivax in rural amazonia. J Infect Dis 195: 1218-1226.
48. Imwong M, Nair S, Pukrittayakamee S, Sudimack D, Williams JT, et al. (2007) Contrasting genetic structure in Plasmodium vivax populations from Asia and south America. Int J Parasitol 37: 1013-1022.
49. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, et al. (2007) Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 195: 927-933.
50. Karunaweera ND, Ferreira MU, Hartl DL, Wirth DF, (2007) Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasmodium vivax. Mol Ecol Notes 7: 172-175.
51. McKenzie FE, Jeffery GM, Collins WE, (2007) Gametocytemia and fever in human malaria infections. J Parasitol 93: 627-633.
52. Krotoski WA, (1989) The hypnozoite and malarial relapse. Prog Clin Parasitol 1: 1-19.
53. Chootong P, Ntumngia F, Vanbuskirk K, Xainli J, Cole-Tobian J, et al. (2010) Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory Antibodies. Infect Immun 78: 1089-1095.
54. Cole-Tobian J, King CL, (2003) Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol Biochem Parasitol 127: 121-132.
55. Xainli J, Baisor M, Kastens W, Bockarie M, Adams J, et al. (2002) Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol 169: 3200-3207.
56. Saravia C, Martinez P, Granados D, Lopez C, Reyes C, et al. (2008) Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein. Biochem Biophys Res Commun 377: 1279-1283.
57. Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, et al. (2008) Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc Natl Acad Sci U S A 105: 7857-7862.
58. Trager W, Jensen JB, (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
59. Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, et al. (2003) Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 47: 170-173.
60. Udomsangpetch R, Somsri S, Panichakul T, Chotivanich K, Sirichaisinthop J, et al. (2007) Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int 56: 65-69.
61. Hans D, Pattnaik P, Bhattacharyya A, Shakri AR, Yazdani SS, et al. (2005) Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol 55: 1423-1434.
62. Barry AE, Schultz L, Buckee CO, Reeder JC, (2009) Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS One 4: e8497.
63. Cole-Tobian JL, Michon P, Dabod E, Mueller I, King CL, (2007) Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein Polymorphisms in relation to Parasitemia levels in Papua new guinean children. Am J Trop Med Hyg 77: 955-962.